| UniProt ID | NNMT_HUMAN | |
|---|---|---|
| UniProt AC | P40261 | |
| Protein Name | Nicotinamide N-methyltransferase | |
| Gene Name | NNMT | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 264 | |
| Subcellular Localization | Cytoplasm. | |
| Protein Description | Catalyzes the N-methylation of nicotinamide and other pyridines to form pyridinium ions. This activity is important for biotransformation of many drugs and xenobiotic compounds.. | |
| Protein Sequence | MESGFTSKDTYLSHFNPRDYLEKYYKFGSRHSAESQILKHLLKNLFKIFCLDGVKGDLLIDIGSGPTIYQLLSACESFKEIVVTDYSDQNLQELEKWLKKEPEAFDWSPVVTYVCDLEGNRVKGPEKEEKLRQAVKQVLKCDVTQSQPLGAVPLPPADCVLSTLCLDAACPDLPTYCRALRNLGSLLKPGGFLVIMDALKSSYYMIGEQKFSSLPLGREAVEAAVKEAGYTIEWFEVISQSYSSTMANNEGLFSLVARKLSRPL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MESGFTSKDT -----CCCCCCCCCC | 37.60 | - | |
| 8 | 2-Hydroxyisobutyrylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | - | |
| 8 | Ubiquitination | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | - | |
| 8 | Succinylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | 23954790 | |
| 8 | Acetylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | 27452117 | |
| 8 | "N6,N6-dimethyllysine" | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | - | |
| 8 | Methylation | MESGFTSKDTYLSHF CCCCCCCCCCCHHHC | 51.54 | 23644510 | |
| 11 | Phosphorylation | GFTSKDTYLSHFNPR CCCCCCCCHHHCCHH | 19.15 | 25159151 | |
| 13 | Phosphorylation | TSKDTYLSHFNPRDY CCCCCCHHHCCHHHH | 18.67 | 28857561 | |
| 23 | Ubiquitination | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | - | |
| 23 | Succinylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | 23954790 | |
| 23 | 2-Hydroxyisobutyrylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | - | |
| 23 | Acetylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | 27178108 | |
| 23 | Malonylation | NPRDYLEKYYKFGSR CHHHHHHHHHHHCCC | 51.81 | 26320211 | |
| 24 | Phosphorylation | PRDYLEKYYKFGSRH HHHHHHHHHHHCCCC | 11.51 | - | |
| 25 | Phosphorylation | RDYLEKYYKFGSRHS HHHHHHHHHHCCCCC | 15.77 | - | |
| 26 | Malonylation | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | 26320211 | |
| 26 | 2-Hydroxyisobutyrylation | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | - | |
| 26 | Acetylation | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | 26051181 | |
| 26 | Ubiquitination | DYLEKYYKFGSRHSA HHHHHHHHHCCCCCH | 39.91 | - | |
| 29 | Phosphorylation | EKYYKFGSRHSAESQ HHHHHHCCCCCHHHH | 29.92 | 27690223 | |
| 32 | Phosphorylation | YKFGSRHSAESQILK HHHCCCCCHHHHHHH | 32.40 | 20068231 | |
| 35 | Phosphorylation | GSRHSAESQILKHLL CCCCCHHHHHHHHHH | 23.41 | 20068231 | |
| 39 | Acetylation | SAESQILKHLLKNLF CHHHHHHHHHHHHHH | 33.56 | 19608861 | |
| 39 | Ubiquitination | SAESQILKHLLKNLF CHHHHHHHHHHHHHH | 33.56 | 19608861 | |
| 39 | Malonylation | SAESQILKHLLKNLF CHHHHHHHHHHHHHH | 33.56 | 26320211 | |
| 43 | Acetylation | QILKHLLKNLFKIFC HHHHHHHHHHHHHHC | 58.95 | 23954790 | |
| 43 | Ubiquitination | QILKHLLKNLFKIFC HHHHHHHHHHHHHHC | 58.95 | - | |
| 47 | Ubiquitination | HLLKNLFKIFCLDGV HHHHHHHHHHCCCCC | 37.73 | - | |
| 47 | 2-Hydroxyisobutyrylation | HLLKNLFKIFCLDGV HHHHHHHHHHCCCCC | 37.73 | - | |
| 47 | Acetylation | HLLKNLFKIFCLDGV HHHHHHHHHHCCCCC | 37.73 | 26051181 | |
| 96 | Ubiquitination | QNLQELEKWLKKEPE HCHHHHHHHHHHCCC | 71.14 | - | |
| 100 | Ubiquitination | ELEKWLKKEPEAFDW HHHHHHHHCCCCCCC | 76.08 | - | |
| 108 | Phosphorylation | EPEAFDWSPVVTYVC CCCCCCCCCEEEEEE | 15.06 | 25159151 | |
| 113 | Phosphorylation | DWSPVVTYVCDLEGN CCCCEEEEEEECCCC | 6.35 | 24927040 | |
| 123 | Ubiquitination | DLEGNRVKGPEKEEK ECCCCCCCCHHHHHH | 66.56 | - | |
| 136 | Ubiquitination | EKLRQAVKQVLKCDV HHHHHHHHHHHCCCC | 37.39 | - | |
| 185 | Phosphorylation | RALRNLGSLLKPGGF HHHHHHHHHCCCCEE | 33.42 | 24719451 | |
| 201 | Phosphorylation | VIMDALKSSYYMIGE EEEEHHHHCEEEECC | 25.15 | 27642862 | |
| 203 | Phosphorylation | MDALKSSYYMIGEQK EEHHHHCEEEECCCC | 12.25 | 27642862 | |
| 204 | Phosphorylation | DALKSSYYMIGEQKF EHHHHCEEEECCCCC | 5.56 | 27642862 | |
| 205 | Sulfoxidation | ALKSSYYMIGEQKFS HHHHCEEEECCCCCC | 2.11 | 30846556 | |
| 210 | Ubiquitination | YYMIGEQKFSSLPLG EEEECCCCCCCCCCC | 42.80 | - | |
| 261 | Phosphorylation | SLVARKLSRPL---- HHHHHHHCCCC---- | 34.58 | 23927012 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NNMT_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NNMT_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NNMT_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| GLOD4_HUMAN | GLOD4 | physical | 26344197 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00627 | Niacin |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-39, AND MASS SPECTROMETRY. | |